$VNDA·4

Vanda Pharmaceuticals Inc. · Apr 21, 4:21 PM ET

Vanda Pharmaceuticals Inc. 4

4 · Vanda Pharmaceuticals Inc. · Filed Apr 21, 2015

Insider Transaction Report

Form 4
Period: 2015-04-20
Gibbs Thomas Edward
SVP, Chief Commercial Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2015-04-20+175,000175,000 total
    Exercise: $10.05Exp: 2025-04-19Common Stock (175,000 underlying)
  • Award

    Restricted Stock Units

    2015-04-20+60,00060,000 total
    Common Stock (60,000 underlying)
Footnotes (4)
  • [F1]This option vests and becomes exercisable with respect to 1/4 of the shares subject to this option on April 20, 2016 (the "Initial Vesting Date"), provided Reporting Person remains continously employed by the Issuer through the Initial Vesting Date, and with respect to the remaining 3/4 of the shares in 36 equal monthly installments beginning on May 20, 2016, provided Reporting Person remains continously employed by the Issuer through each monthly vesting date.
  • [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive a share of the Issuer's common stock.
  • [F3]The RSUs shall vest in four (4) equal annual installments beginning January 1, 2016, provided Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissable Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.
  • [F4]Not applicable.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION